Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 25 results:
Συντάκτης [ Τίτλος] Τύπος Έτος Φίλτρα: Συντάκτης is Antza, Christina [Clear All Filters]
Body composition and arterial stiffness in pediatric patients with chronic kidney disease..
Pediatr Nephrol. 34(7), 1253-1260.
(2019). Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH)..
Atherosclerosis. 277, 308-313.
(2018). Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence..
Vasc Health Risk Manag. 12, 443-451.
(2016). Comparison Among Recommendations for the Management of Arterial Hypertension Issued by Last US, Canadian, British and European Guidelines..
High Blood Press Cardiovasc Prev. 25(1), 9-16.
(2018).
(2019). Early Vascular Aging: A New Target for Hypertension Treatment..
Curr Pharm Des. 22(1), 122-6.
(2015). Early Vascular Aging Risk Assessment From Ambulatory Blood Pressure Monitoring: The Early Vascular Aging Ambulatory Score..
Am J Hypertens. 31(11), 1197-1204.
(2018). The flipside of hydralazine in pregnancy: A systematic review and meta-analysis..
Pregnancy Hypertens. 19, 177-186.
(2020). A gut feeling about children's exposure to hypertensive disorders of pregnancy in utero..
Eur J Prev Cardiol. 2047487319857213.
(2019). Hypertension in obesity: novel insights..
Curr Hypertens Rev.
(2019). Markers of Early Vascular Ageing..
Curr Pharm Des. 23(22), 3200-3204.
(2017). Masked and white coat hypertension, the double trouble of large arteries: A systematic review and meta-analysis..
J Clin Hypertens (Greenwich). 22(5), 802-811.
(2020). New developments in the pathogenesis of obesity-induced hypertension..
J Hypertens. 33(8), 1499-508.
(2015). Non-Vitamin K Antagonist Oral Anticoagulants in Pulmonary Embolism: An Overview of Systematic Reviews..
Curr Pharm Des. 26(23), 2686-2691.
(2020). Non-vitamin K oral anticoagulants in nonvalvular atrial fibrillation: a network meta-analysis..
Scand Cardiovasc J. 53(2), 48-54.
(2019). Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension.
J Hypertens. 36(7), 1427-1440.
(2018). Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease, ea.
J Hypertens. 36(7), 1441-1455.
(2018). Obesity and season as determinants of high blood pressure in a school-based screening study..
J Hum Hypertens. 33(4), 277-285.
(2019). Obesity-Induced Hypertension: New Insights..
Curr Pharm Des. 23(31), 4620-4625.
(2017). Overview of Systematic Reviews of Non-Vitamin K Oral Anticoagulants in Atrial Fibrillation..
Circ Cardiovasc Qual Outcomes. 11(12), e004769.
(2018). Performance of simplified tables for high blood pressure screening in a European pediatric population..
J Hypertens. 37(5), 917-922.
(2019). Screening for Malnutrition Among People Accessing Health Services at Greek Public Hospitals: Results From an Observational Multicenter Study..
JPEN J Parenter Enteral Nutr. 42(4), 709-718.
(2018). Subclinical arterial damage in children and adolescents with type 1 diabetes: A systematic review and meta-analysis..
Pediatr Diabetes. 20(6), 668-677.
(2019).
(2019).
(2020).